These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 33756019)

  • 1. Cephalosporins for first febrile urinary tract infection from Enterobacteriaceae with antimicrobial resistance in young children.
    Rianthavorn P; Siripen N; Kunnaruk K
    Acta Paediatr; 2021 Jul; 110(7):2230-2232. PubMed ID: 33756019
    [No Abstract]   [Full Text] [Related]  

  • 2. Etiologies of community-onset urinary tract infections requiring hospitalization and antimicrobial susceptibilities of causative microorganisms.
    Chiu CC; Lin TC; Wu RX; Yang YS; Hsiao PJ; Lee Y; Lin JC; Chang FY
    J Microbiol Immunol Infect; 2017 Dec; 50(6):879-885. PubMed ID: 28087318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefepime-Taniborbactam in Complicated Urinary Tract Infection.
    van Os W; Zeitlinger M
    N Engl J Med; 2024 May; 390(20):1937-1938. PubMed ID: 38810200
    [No Abstract]   [Full Text] [Related]  

  • 4. Cefepime-Taniborbactam in Complicated Urinary Tract Infection.
    Lanini S; Cai T; Tascini C
    N Engl J Med; 2024 May; 390(20):1937. PubMed ID: 38810199
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of Clinical and Laboratory Standards Institute breakpoint changes on susceptibility rates of cephalosporins in uncomplicated urinary tract infections caused by Enterobacteriaceae.
    Bunnell KL; Wenzler E; Harrington AT; Danziger LH
    Diagn Microbiol Infect Dis; 2018 Apr; 90(4):335-336. PubMed ID: 29395714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Febrile urinary-tract infection due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in children: A French prospective multicenter study.
    Madhi F; Jung C; Timsit S; Levy C; Biscardi S; Lorrot M; Grimprel E; Hees L; Craiu I; Galerne A; Dubos F; Cixous E; Hentgen V; Béchet S; ; Bonacorsi S; Cohen R
    PLoS One; 2018; 13(1):e0190910. PubMed ID: 29370234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary Tract Infection in Outpatient Children and Adolescents: Risk Analysis of Antimicrobial Resistance.
    Eremenko R; Barmatz S; Lumelsky N; Colodner R; Strauss M; Alkan Y
    Isr Med Assoc J; 2020 Apr; 22(4):236-240. PubMed ID: 32286027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Profile of antimicrobial resistance of agents causing urinary tract infections in children].
    Ghedira Besbes L; Messaoudi A; Ben Meriem C; Guediche MN
    Tunis Med; 2004 Mar; 82(3):299-305. PubMed ID: 15382465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switching from CLSI to EUCAST XL susceptibility breakpoint: its implication in urinary tract infection in men.
    Aguirre-Quiñonero A; Lecaroz Agara MC; Canut Blasco A
    Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1813-1815. PubMed ID: 29936620
    [No Abstract]   [Full Text] [Related]  

  • 10. Empiric antimicrobial therapy of serious urinary tract infections.
    File TM; Tan JS
    Urology; 1986 Jan; 27(1):80-5. PubMed ID: 3510503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefepime versus carbapenems for the treatment of urinary tract infections caused by extended-spectrum β-lactamase-producing enterobacteriaceae.
    Kim SA; Altshuler J; Paris D; Fedorenko M
    Int J Antimicrob Agents; 2018 Jan; 51(1):155-158. PubMed ID: 28943367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reanalysis of cefazolin surrogate susceptibility breakpoints utilized as guidances for oral cephalosporin treatments of uncomplicated urinary tract infections: caution concerning application to cefadroxil.
    Nguyen HM; Jones RN
    Diagn Microbiol Infect Dis; 2020 Jul; 97(3):115053. PubMed ID: 32349909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of Raoultella ornithinolytica urinary tract infection in a pediatric patient.
    Büyükcam A; Liste Ü; Bıçakçıgil A; Kara A; Sancak B
    J Infect Chemother; 2019 Jun; 25(6):467-469. PubMed ID: 30683499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [ESBL--increasing resistance problems. Cephalosporins no longer obvious choice in diffuse infections].
    Hallgren H; Gustafsson I; Ripa T
    Lakartidningen; 2007 Dec; 104(51-52):3883-5. PubMed ID: 18232531
    [No Abstract]   [Full Text] [Related]  

  • 15. The presence of urinary nitrites is a significant predictor of pediatric urinary tract infection susceptibility to first- and third-generation cephalosporins.
    Weisz D; Seabrook JA; Lim RK
    J Emerg Med; 2010 Jul; 39(1):6-12. PubMed ID: 18757159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ceftibuten (Cedax)--a novel third generation oral cephalosporin in the treatment of bacterial infections].
    Budanov SV
    Antibiot Khimioter; 1998; 43(4):33-9. PubMed ID: 9606503
    [No Abstract]   [Full Text] [Related]  

  • 17. Cefepime-Taniborbactam in Complicated Urinary Tract Infection.
    Manesh A; Varghese GM; Paterson DL
    N Engl J Med; 2024 May; 390(20):1938. PubMed ID: 38810201
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of age and sex in determining antibiotic resistance in febrile urinary tract infections.
    Lee DS; Choe HS; Kim HY; Yoo JM; Bae WJ; Cho YH; Kim SW; Han CH; Bae SR; Jang H; Park SB; Yoon BI; Lee SJ
    Int J Infect Dis; 2016 Oct; 51():89-96. PubMed ID: 27575938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoroquinolones for urinary tract infection and within-household spread of resistant Enterobacteriaceae: the smoking gun.
    Trautner BW
    Clin Microbiol Infect; 2018 Sep; 24(9):929-930. PubMed ID: 29649605
    [No Abstract]   [Full Text] [Related]  

  • 20. Antimicrobial sensitivity pattern of organisms causing urinary tract infection in children with sickle cell anemia in Maiduguri, Nigeria.
    Mava Y; Bello M; Ambe JP; Zailani SB
    Niger J Clin Pract; 2012; 15(4):420-3. PubMed ID: 23238191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.